Related Experiment Videos
Hepatic tumorigenesis in acute hepatic failure
Daniel Baumhoer1, Thomas Lorf, Bastian Gunawan
1Department of Gastroenterology and Endocrinology, University of Göttingen, Göttingen, Germany.
European Journal of Gastroenterology & Hepatology
|September 9, 2005
Summary
Drug toxicity caused acute liver failure in two patients who underwent liver transplantation. Their explanted livers showed early-stage liver cancer, suggesting tumorigenesis may occur alongside or be induced by liver failure.
Area of Science:
- Hepatology
- Oncology
- Transplantation Medicine
Background:
- Acute liver failure (ALF) is a rare but life-threatening condition.
- Drug-induced liver injury (DILI) is a leading cause of ALF.
- Primary liver cancer is infrequently associated with ALF.
Observation:
- Two patients (59-year-old female, 31-year-old male) presented with ALF, likely due to drug toxicity.
- Both patients required urgent liver transplantation.
- Histopathological examination of explanted livers revealed incidental hepatocellular carcinoma (HCC) and dysplastic nodules.
Findings:
- The study identified early-stage hepatocellular carcinoma in patients with drug-induced acute liver failure.
- The presence of liver cancer was incidental and not the primary cause of liver failure.
- Tumorigenesis may occur concurrently with or be a consequence of progressive liver failure.
Implications:
- These findings challenge the traditional view of liver cancer as a sole cause of hepatic failure.
- Highlights the importance of thorough histopathological evaluation in ALF cases.
- Suggests a potential link between severe liver injury and the induction or acceleration of hepatic tumorigenesis.